Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Xenon Pharmaceuticals Inc., 3 years.
Xenon Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Xenon Pharmaceuticals Inc. June 4, 202598.7%
-
Xenon Pharmaceuticals Inc. June 4, 202498.4%
-
Xenon Pharmaceuticals Inc. June 1, 202395.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −1,322 | $53.14 | $70,251 |
| Jun 1, 2026 | Xenon Pharmaceuticals Inc. | Option exercise | +2,645 | — | — |
| Nov 22, 2024 | Xenon Pharmaceuticals Inc. | Option exercise | +3,500 | $7.38 | $25,830 |
| Nov 22, 2024 | Xenon Pharmaceuticals Inc. | Shares withheld for tax | −649 | $39.80 | $25,830 |
| Nov 22, 2024 | Xenon Pharmaceuticals Inc. | Open-market sale | −2,851 | $41.11 | $117,205 |
| Nov 22, 2024 | Xenon Pharmaceuticals Inc. | Option exercise | +3,086 | $13.48 | $41,599 |
| Nov 22, 2024 | Xenon Pharmaceuticals Inc. | Shares withheld for tax | −1,046 | $39.80 | $41,631 |
| Nov 22, 2024 | Xenon Pharmaceuticals Inc. | Open-market sale | −2,040 | $41.05 | $83,742 |
| Dec 13, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +6,378 | $9.85 | $62,823 |
| Dec 13, 2023 | Xenon Pharmaceuticals Inc. | Shares withheld for tax | −1,278 | $39.68 | $50,711 |
| Dec 13, 2023 | Xenon Pharmaceuticals Inc. | Open-market sale | −5,100 | $38.94 | $198,594 |
| Dec 13, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +2,880 | $9.85 | $28,368 |
| Dec 13, 2023 | Xenon Pharmaceuticals Inc. | Shares withheld for tax | −577 | $39.68 | $22,895 |
| Dec 13, 2023 | Xenon Pharmaceuticals Inc. | Open-market sale | −2,303 | $39.10 | $90,047 |
| Dec 13, 2023 | Xenon Pharmaceuticals Inc. | Option exercise | +5,144 | $9.00 | $46,296 |
Questions about Gary Patou
What boards is Gary Patou on?
Gary Patou sits on the board of Xenon Pharmaceuticals Inc.
How long has Gary Patou served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.